Filtered By:
Source: The Annals of Pharmacotherapy
Condition: Bleeding
This page shows you your search results in order of date.
Order by Relevance | Date
Total 41 results found since Jan 2013.
Off-Label Reduced Dose Apixaban in Older Adults With Atrial Fibrillation and Associated Outcomes
CONCLUSION AND RELEVANCE: Older adults with nonvalvular AF are commonly prescribed lower-than-recommended doses of apixaban. However, no significant association was found between empiric off-label reduced dosing and stroke or bleeding outcomes.PMID:37712551 | DOI:10.1177/10600280231199137
Source: The Annals of Pharmacotherapy - September 15, 2023 Category: Drugs & Pharmacology Authors: Ashley M Campbell Elizabeth Pae Eunice Lee Timothy Jacisin Alina Price Jessica DeAngelo Source Type: research
Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke
CONCLUSIONS AND RELEVANCE: Tenecteplase had similar rates of major bleeding versus alteplase and may be a reasonable alternative in the treatment of acute ischemic stroke.PMID:36004394 | DOI:10.1177/10600280221120211
Source: The Annals of Pharmacotherapy - August 25, 2022 Category: Drugs & Pharmacology Authors: Mary N Walton Leslie A Hamilton Sonia Salyer Brian F Wiseman Ann M Forster A Shaun Rowe Source Type: research
Perioperative Antiplatelet Bridging With Cangrelor: A Cohort Study and Narrative Review
CONCLUSION AND RELEVANCE: This study suggests that cangrelor bridging may be a reasonable alternative to holding oral P2Y12 inhibitors in patients requiring interruption of antiplatelet therapy for an urgent surgery/invasive procedure.PMID:36004393 | DOI:10.1177/10600280221120310
Source: The Annals of Pharmacotherapy - August 25, 2022 Category: Drugs & Pharmacology Authors: Alok Salgia Chelsea K Krueger Michael A Gillette Source Type: research
Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke
CONCLUSIONS AND RELEVANCE: Tenecteplase had similar rates of major bleeding versus alteplase and may be a reasonable alternative in the treatment of acute ischemic stroke.PMID:36004394 | DOI:10.1177/10600280221120211
Source: The Annals of Pharmacotherapy - August 25, 2022 Category: Drugs & Pharmacology Authors: Mary N Walton Leslie A Hamilton Sonia Salyer Brian F Wiseman Ann M Forster A Shaun Rowe Source Type: research
Perioperative Antiplatelet Bridging With Cangrelor: A Cohort Study and Narrative Review
CONCLUSION AND RELEVANCE: This study suggests that cangrelor bridging may be a reasonable alternative to holding oral P2Y12 inhibitors in patients requiring interruption of antiplatelet therapy for an urgent surgery/invasive procedure.PMID:36004393 | DOI:10.1177/10600280221120310
Source: The Annals of Pharmacotherapy - August 25, 2022 Category: Drugs & Pharmacology Authors: Alok Salgia Chelsea K Krueger Michael A Gillette Source Type: research
Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke
CONCLUSIONS AND RELEVANCE: Tenecteplase had similar rates of major bleeding versus alteplase and may be a reasonable alternative in the treatment of acute ischemic stroke.PMID:36004394 | DOI:10.1177/10600280221120211
Source: The Annals of Pharmacotherapy - August 25, 2022 Category: Drugs & Pharmacology Authors: Mary N Walton Leslie A Hamilton Sonia Salyer Brian F Wiseman Ann M Forster A Shaun Rowe Source Type: research
Perioperative Antiplatelet Bridging With Cangrelor: A Cohort Study and Narrative Review
CONCLUSION AND RELEVANCE: This study suggests that cangrelor bridging may be a reasonable alternative to holding oral P2Y12 inhibitors in patients requiring interruption of antiplatelet therapy for an urgent surgery/invasive procedure.PMID:36004393 | DOI:10.1177/10600280221120310
Source: The Annals of Pharmacotherapy - August 25, 2022 Category: Drugs & Pharmacology Authors: Alok Salgia Chelsea K Krueger Michael A Gillette Source Type: research
Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke
CONCLUSIONS AND RELEVANCE: Tenecteplase had similar rates of major bleeding versus alteplase and may be a reasonable alternative in the treatment of acute ischemic stroke.PMID:36004394 | DOI:10.1177/10600280221120211
Source: The Annals of Pharmacotherapy - August 25, 2022 Category: Drugs & Pharmacology Authors: Mary N Walton Leslie A Hamilton Sonia Salyer Brian F Wiseman Ann M Forster A Shaun Rowe Source Type: research
Perioperative Antiplatelet Bridging With Cangrelor: A Cohort Study and Narrative Review
CONCLUSION AND RELEVANCE: This study suggests that cangrelor bridging may be a reasonable alternative to holding oral P2Y12 inhibitors in patients requiring interruption of antiplatelet therapy for an urgent surgery/invasive procedure.PMID:36004393 | DOI:10.1177/10600280221120310
Source: The Annals of Pharmacotherapy - August 25, 2022 Category: Drugs & Pharmacology Authors: Alok Salgia Chelsea K Krueger Michael A Gillette Source Type: research
